On February 16, the American Cancer Society National Consortium for Cancer Screening and Care (ACS National Consortium) released a set of consensus recommendations in a new report Responding to the COVID-19 Pandemic: Improving Cancer Screening and Care in the US. Companion materials are also available.
The ACS National Consortium launched in March 2021 with the aim to quicken the nation’s collective response to the COVID-19 pandemic’s detrimental impact on cancer screening and care. The group represents a diverse, multi-sector coalition of 28 organizational members including government agencies, leading cancer advocacy organizations, professional societies, research institutions, national roundtables, leading health organizations, and other relevant industry leaders and partners.
More information can be found here at consortium.acs4ccc.org.